FORT LAUDERDALE, Fla., June 9, 2016 /PRNewswire/ -- Endocure Technologies, Inc., our medical R&D and OEM company, has received FDA 510(k) clearance for its Endocure EUR078A forward looking, American made, Ureteroscope. The EUR078A will be manufactured in the USA and represents a major step forward in technology and ergonomics which medical professionals will come to appreciate. We have been able to achieve this level of success due to our 25-year history of repairing sophisticated flexible endoscopes and other medical instruments combined with our experienced engineering and technical staff to develop this scope.
MedServ Technologies, Inc. (MST) is a holding company, based in Fort Lauderdale, FL, with focus on the healthcare industry and comprised of highly innovative companies providing manufactured products and repair/replacement parts for rigid and flexible endoscopes, as well as other surgical instruments through its wholly owned subsidiaries, MedServ International, Inc. (MSI), Endosurg Medical, Inc. (EMI) Endocure Technologies, Inc. (ETI) and HMB Endoscopy (HMB).
MSI, EMI and HMB are service subsidiaries dedicated to the repair and manufacture of parts for the endoscopic and minimally invasive instrumentation marketplace. HMB also specializes in the resale of refurbished endoscopic and related equipment. MSI, EMI and ETI are located in a 19,000 square foot facility in Beltsville, MD while HMB is located in a 9,000 sq. ft. facility in Fort Lauderdale, FL.
"Our company and its employees are excited to enter a new era in our evolution as a medical innovation company with this new Urology offering," stated Joe Rotmil, President and CEO of Medserv Technologies, Inc.
For further information, contact:
VP Sales and Marketing
Safe Harbor Forward-Looking Statements
To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endocure-technologies-inc-a-wholly-owned-subsidiary-of-medserv-technologies-inc-has-received-fda-510k-clearance-for-the-manufacture-of-its-new-endocure-model-eur078a-urology-endoscope-300282616.html
SOURCE MedServ Technologies, Inc.